RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Provides Update on Australian Clinical Study, page-21

  1. 26,834 Posts.
    lightbulb Created with Sketch. 1738
    I think the are looking at the first US clinical trials numbers of around 1000 patient and given it's only 1 hospital it expected to be slow but will pick up this Winter I guess......

    "Australian Paediatric Clinical Study
    During the period, the Company continued to enrol children in its Australian paediatric clinical study. On 4 September 2017, ResApp announced it plans to broaden its paediatric clinical strategy by reconfiguring its Australian study to directly support European (CE) and Australian (TGA) regulatory filings. Since early 2017, the Australian paediatric study at Joondalup Hospital has been recruiting patients for double-blind prospective analysis with 230 patients recruited as at September 2017. To support regulatory submissions, a team of clinicians will perform adjudication and Curtin University health researchers will provide independent statistical analysis."
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.